Login to Your Account

Biogen shares rise as company stays steady despite challenges

By Michael Fitzhugh
Staff Writer

Thursday, January 26, 2017

Despite a 22 percent decline in Biogen Inc.’s fourth-quarter income, attributable mostly to its recent settlement with Forward Pharma A/S, company shares climbed 2 percent to $278.89 on Thursday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription